Analyze Diet
Equine veterinary journal2012; 45(2); 199-203; doi: 10.1111/j.2042-3306.2012.00594.x

Determination of serum anti-Müllerian hormone concentrations for the diagnosis of granulosa-cell tumours in mares.

Abstract: Endocrinological assays are important for evaluation of mares with granulosa-cell tumours (GCTs), and our research in mares indicates that anti-Müllerian hormone (AMH) may be a good biomarker for this type of ovarian tumour. Objective: To evaluate the use of serum AMH concentrations for endocrine diagnosis of GCTs in mares. Methods: Archived serum samples (n = 403) previously assayed for determination of serum inhibin, testosterone and progesterone concentrations (GCT panel) were assayed for serum AMH concentrations using a heterologous enzyme-linked immunosorbent assay previously validated by our laboratory. For a subset (n = 44) of these samples, a clinical diagnosis of GCT was confirmed by histopathology. Results: Overall, the sensitivity of AMH (98%) for detection of histologically confirmed GCTs was significantly (P<0.05) greater than that of either inhibin (80%) or testosterone (48%) or the combination of inhibin and testosterone (84%). Conclusions: Determination of serum AMH concentrations is a useful biomarker for detection of GCTs in the mare. Conclusions: Measurement of serum AMH concentrations can be used for diagnosis of GCTs in the mare. As serum AMH concentrations do not vary significantly during the oestrous cycle or pregnancy, interpretation of these results is not confounded by these physiological states.
Publication Date: 2012-07-11 PubMed ID: 22779762DOI: 10.1111/j.2042-3306.2012.00594.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article presents a study on the use of anti-Müllerian hormone (AMH) as a biomarker for detecting granulosa-cell tumours (GCTs) in mares, indicating that AMH measurements provide a more sensitive and consistent means of diagnosis compared to prior methods.

Research Objective

  • The primary objective of this research was to evaluate the effectiveness of serum AMH concentrations as an endocrine diagnostic method for GCTs in mares. This test aims to provide a more reliable, precise method for diagnosing this type of ovarian tumour in horses.

Research Method

  • The researchers used a sample of 403 archived serum, which had been previously tested for inhibin, testosterone, and progesterone concentrations, which are substances commonly used to identify GCTs.
  • The samples were retested, this time for AMH concentrations, using a heterologous enzyme-linked immunosorbent assay (a test that measures the concentration of a specific substance in a liquid sample), which had been previously authenticated by the researchers’ laboratory.
  • A subset of these samples (44 in total) had been previously confirmed to have GCTs through histopathology (the examination of tissue to study the manifestations of disease).

Research Results

  • The research evidenced that the use of AMH had a significantly greater sensitivity (98%) for the detection of GCTs compared to inhibin (80%), testosterone (48%), or the combination of both inhibin and testosterone (84%).
  • This means that the measurement of serum AMH concentrations was more accurate and produced fewer false negatives than other tested substances.

Research Conclusions

  • The study concluded that using serum AMH concentrations as a biomarker provides an efficacious method for the detection of GCTs in mares.
  • A crucial advantage of this method is that AMH concentrations don’t significantly vary during different physiological states such as the oestrous cycle or pregnancy, hence, the interpretation of the results is not affected during these periods. This makes AMH a more reliable biomarker for the detection of GCTs.

Cite This Article

APA
Ball BA, Almeida J, Conley AJ. (2012). Determination of serum anti-Müllerian hormone concentrations for the diagnosis of granulosa-cell tumours in mares. Equine Vet J, 45(2), 199-203. https://doi.org/10.1111/j.2042-3306.2012.00594.x

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 45
Issue: 2
Pages: 199-203

Researcher Affiliations

Ball, B A
  • Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, USA. b.a.ball@uky.edu
Almeida, J
    Conley, A J

      MeSH Terms

      • Animals
      • Anti-Mullerian Hormone / blood
      • Estrous Cycle / blood
      • Estrous Cycle / physiology
      • Female
      • Granulosa Cell Tumor / diagnosis
      • Granulosa Cell Tumor / veterinary
      • Horse Diseases / blood
      • Horse Diseases / diagnosis
      • Horses
      • Inhibins / blood
      • Pregnancy
      • Retrospective Studies
      • Sensitivity and Specificity
      • Testosterone / blood

      Citations

      This article has been cited 8 times.
      1. Straticò P, Hattab J, Guerri G, Carluccio A, Bandera L, Celani G, Marruchella G, Varasano V, Petrizzi L. Behavioral Disorders in Mares with Ovarian Disorders, Outcome after Laparoscopic Ovariectomy: A Case Series.. Vet Sci 2023 Jul 25;10(8).
        doi: 10.3390/vetsci10080483pubmed: 37624270google scholar: lookup
      2. Dolin A, Schweiger P, Waselau M, Egerbacher M, Walter I. Immunohistochemical markers for equine granulosa cell tumors: a pilot study.. J Equine Sci 2023 Jun;34(2):37-46.
        doi: 10.1294/jes.34.37pubmed: 37405069google scholar: lookup
      3. Drozdzewska K, Gehlen H. Markers for internal neoplasia in the horse.. Vet Med Sci 2023 Jan;9(1):132-143.
        doi: 10.1002/vms3.1042pubmed: 36495211google scholar: lookup
      4. Colombe P, Béguin J, Benchekroun G, Le Roux D. Blood biomarkers for canine cancer, from human to veterinary oncology.. Vet Comp Oncol 2022 Dec;20(4):767-777.
        doi: 10.1111/vco.12848pubmed: 35815441google scholar: lookup
      5. Goto A, Tagami M, Kato F, Suzuki T, Yamaga T, Murase H, Sato F, Tsogtgerel M, Niikura T, Moriyama T, Chiba A, Watanabe KI, Tsuzuki N, Nambo Y. Equine nonneoplastic abnormal ovary in a draft mare with high serum anti-Müllerian hormone: a case study.. J Equine Sci 2021 Dec;32(4):147-151.
        doi: 10.1294/jes.32.147pubmed: 35023993google scholar: lookup
      6. Tsogtgerel M, Tagami M, Watanabe K, Murase H, Hirosawa Y, Kobayashi Y, Nambo Y. Case report: The case of a 17 kg ovarian granulosa cell tumor in a Breton draft mare.. J Equine Sci 2021 Jun;32(2):67-72.
        doi: 10.1294/jes.32.67pubmed: 34220274google scholar: lookup
      7. Devick IF, Leise BS, McCue PM, Rao S, Hendrickson DA. Ovarian histopathology, pre- and post-operative endocrinological analysis and behavior alterations in 27 mares undergoing bilateral standing laparoscopic ovariectomy.. Can Vet J 2020 Feb;61(2):181-186.
        pubmed: 32020939
      8. Umer S, Zhao SJ, Sammad A, Weldegebriall Sahlu B, Yunwei P, Zhu H. AMH: Could It Be Used as A Biomarker for Fertility and Superovulation in Domestic Animals?. Genes (Basel) 2019 Dec 4;10(12).
        doi: 10.3390/genes10121009pubmed: 31817280google scholar: lookup